Unión Europea - español - EMA (European Medicines Agency)

roche registration gmbh  - risdiplam - atrofia muscular, espinal - otras drogas para trastornos del sistema musculoesquelético - evrysdi is indicated for the treatment of 5q spinal muscular atrophy (sma) in patients with a clinical diagnosis of sma type 1, type 2 or type 3 or with one to four smn2 copies.

Unión Europea - español - EMA (European Medicines Agency)

teva b.v. - lipegfilgrastim - neutropenia - inmunoestimulantes, , factores estimulantes de colonias - lonquex is indicated in adults and in children 2 years of age and older for reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes).

Unión Europea - español - EMA (European Medicines Agency)

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vacunas - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. el uso de esta vacuna debe estar en conformidad con las recomendaciones oficiales.

Perú - español - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

berinvest s.a.c. - tableta

Perú - español - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

inversiones florencia s.a.c. - tableta masticable

Perú - español - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

drogueria sunshine s.r.ltda. - tableta

Perú - español - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

berinvest s.a.c. - tableta

Perú - español - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

inversiones y distribuidora verdi s.a.c. - droguerÍa - capsula blanda - por capsula - - omega-3-triglicéridos

Perú - español - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

inversiones y distribuidora verdi s.a.c. - droguerÍa - acido eicosapentanoico; acido docosahexanoico; acidos grasos omega-3; vitamina a; - capsula blanda - por capsula - - omega-3-triglicéridos

Perú - español - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

inversiones y distribuidora verdi s.a.c. - droguerÍa - pastilla de goma - por goma - - productos varios para el tracto alimentario y el metabolismo